BriaCell Therapeutics Corp. is a biotech. Over the past three years, BriaCell Therapeutics Corp. has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals). The company currently has 2 active clinical trials, primarily in Oncology.
Deals (12mo)
1
Active Trials
2
Top Modality
Other
Focus Area
Oncology
Licensing, acquisition, and partnership transactions involving BriaCell Therapeutics Corp. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Soluble CD80 | BriaPro Therapeutics Corp. | Other | Preclinical | acquisition | Feb 20, 2026 |
Therapeutic areas and modalities where BriaCell Therapeutics Corp. is most active based on deal history and clinical trial data.
BriaCell Therapeutics Corp. has 2 active clinical trials across 2 development phases.
1
Unknown
1
Phase 3
Use Solidus to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
BriaCell Therapeutics Corp. is a biotech company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, BriaCell Therapeutics Corp. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for BriaCell Therapeutics Corp. include Oncology (2 deals and trials), and Solid Tumors (2 deals and trials). In terms of modality, BriaCell Therapeutics Corp. has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for BriaCell Therapeutics Corp. and 700+ other biopharma companies. Use our Solidus to benchmark your asset against BriaCell Therapeutics Corp.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.